BiVictriX Therapeutics Plc (BVX.L)
GBp 10.0
(17.65%)
GBp 10.0
(17.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.93 Million | -2.39 Million | -1.78 Million | -166 Thousand | -357 Thousand | -484 Thousand |
| Net Income | -2.54 Million | -2.97 Million | -2.53 Million | -490 Thousand | -526 Thousand | -480 Thousand |
| Depreciation & Amortization | 165 Thousand | 151 Thousand | 46 Thousand | 1000.00 | - | - |
| Deferred income taxes | - | - | 84 Thousand | - | - | - |
| Stock-based compensation | 74 Thousand | 127 Thousand | 224 Thousand | 4000.00 | 4000.00 | 2000.00 |
| Change in working capital | 293 Thousand | 88 Thousand | -248 Thousand | 201 Thousand | 63 Thousand | -55 Thousand |
| Other non-cash items | 399 Thousand | 208 Thousand | 641 Thousand | 118 Thousand | 102 Thousand | 49 Thousand |
| Investing Cash Flow | -5000.00 | -379 Thousand | -46 Thousand | -63 Thousand | - | - |
| Investments in PPE | -5000.00 | -389 Thousand | -46 Thousand | -63 Thousand | - | - |
| Acquisitions | - | 10 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.93 Million | - | 7.03 Million | 962 Thousand | 275 Thousand | 553 Thousand |
| Debt repayment | - | - | - | -800 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.05 Million | - | 7.5 Million | 179 Thousand | 287 Thousand | 565 Thousand |
| Other Financing Activities | - | - | -468 Thousand | 1.58 Million | -12 Thousand | -12 Thousand |
| Accounts receivables | 80 Thousand | 63 Thousand | -227 Thousand | -41 Thousand | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 213 Thousand | 25 Thousand | -21 Thousand | 242 Thousand | - | - |
| Cash at beginning of period | 3.28 Million | 6.06 Million | 862 Thousand | 129 Thousand | 211 Thousand | 142 Thousand |
| Cash at end of period | 3.27 Million | 3.28 Million | 6.06 Million | 862 Thousand | 129 Thousand | 211 Thousand |
| Capital Expenditure | -5000.00 | -389 Thousand | -46 Thousand | -63 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8000.00 | -2.77 Million | 5.2 Million | 733 Thousand | -82 Thousand | 69 Thousand |
| Free Cash Flow | -1.94 Million | -2.78 Million | -1.83 Million | -229 Thousand | -357 Thousand | -484 Thousand |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.29 Million | -1.37 Million | -2.54 Million | -1.17 Million | -2.97 Million | -1.15 Million |
| Depreciation & Amortization | 90 Thousand | 89 Thousand | 165 Thousand | 76 Thousand | 151 Thousand | 128 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 74 Thousand | - | 127 Thousand | - |
| Change in working capital | -89 Thousand | 248 Thousand | 293 Thousand | 45 Thousand | 88 Thousand | -54 Thousand |
| Other non-cash items | 22 Thousand | 420 Thousand | 399 Thousand | -21 Thousand | 208 Thousand | 196 Thousand |
| Investing Cash Flow | -4000.00 | 155 Thousand | -5000.00 | -160 Thousand | -379 Thousand | -185 Thousand |
| Investments in PPE | -4000.00 | 155 Thousand | -5000.00 | -160 Thousand | -389 Thousand | -195 Thousand |
| Acquisitions | - | - | - | - | 10 Thousand | 10 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -66 Thousand | 1.93 Million | 1.93 Million | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 2.05 Million | 2.05 Million | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -66 Thousand | 80 Thousand | 80 Thousand | - | 63 Thousand | 67 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -23 Thousand | 168 Thousand | 213 Thousand | 45 Thousand | 25 Thousand | -121 Thousand |
| Cash at beginning of period | 3.27 Million | 1.9 Million | 3.28 Million | 3.28 Million | 6.06 Million | 4.54 Million |
| Cash at end of period | 1.68 Million | 3.27 Million | 3.27 Million | 1.9 Million | 3.28 Million | 3.28 Million |
| Capital Expenditure | -4000.00 | 155 Thousand | -5000.00 | -160 Thousand | -389 Thousand | -195 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.59 Million | 1.37 Million | -8000.00 | -1.38 Million | -2.77 Million | -1.26 Million |
| Free Cash Flow | -1.52 Million | -560 Thousand | -1.94 Million | -1.38 Million | -2.78 Million | -1.27 Million |
TCO0
PREM
WLBMF
BRLAF
LOMLF
HECPROJECT